TNFRSF12A and cancer: Persistent TWEAK-Tnfrsf12a engagement or Tnfrsf12a overexpression contributes to acute ischemic stroke, rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and cancer [5, 6].